Importantly, genetic ablation of Mtss1 accelerated the development of KrasG12D-induced lung cancer in the mice, as evidenced by increased tumor burden in the lungs (Fig. 1d, e) and lung weights (Fig. 1f) in age-matched mice. The gene discussed is MTSS1; the disease is lung carcinoma.